Histopathology, Immunohistochemistry, and Molecular Biology

  • F. Hofstädter


The pathology of thyroid carcinoma is characterized by a defined histopathological classification system that has only undergone minor changes in the past few years, which is the basis of clinical diagnostic and treatment modalities as well as a rapid progress of application of new methods and increasing knowledge of basic mechanisms in molecular pathology. However, at least in the field of C-cell carcinoma, thyroid pathology represents an impressive example of the successful application of molecular pathology in clinical practice. The aim of this review is to summarize the principles of clinical histopathology in thyroid carcinoma followed by a brief analysis of recent work in molecular pathology concentrating on original recent articles on surgical material and revealing some correlations to the questions of diagnostic clinical histopathology.


Thyroid Carcinoma Papillary Thyroid Carcinoma Papillary Carcinoma Medullary Thyroid Carcinoma Follicular Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albareda M, Puig-Domingo M, Wengrowicz S, Soldevila,J, Matias-Guiu X, Caballero A, Chico A, De Leiva A (1998) Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 8: 385–391Google Scholar
  2. 2.
    Albores-Saavedra J, LiVolsi VA, Williams ED (1985) Medullary carcinoma. Semin Diagn Pathol 2: 137–146PubMedGoogle Scholar
  3. 3.
    Albores-Saavedra J, Housine I, Vuitch F, Snyder VM (1997) Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer 80: 1110–1116PubMedCrossRefGoogle Scholar
  4. 4.
    Ando H, Funahashi H, Ito M, Imai T, Takagi H (1996) Proliferating cell nuclear antigen expression in papillary thyroid carcinoma. J Clin Pathol 49: 657–659PubMedCrossRefGoogle Scholar
  5. 5.
    Aust G, Eichler W, Laue S, Lehmann I, Heldin NE, Lotz O, Scherbaum WA, Dralle H, HoangVu C (1997) Cd97: a dedifferentiation marker in human thyroid carcinomas. Cancer Res 57: 1798–1806PubMedGoogle Scholar
  6. 6.
    Balsassarre G, Belletti B, Bnnü P, Bocia A, Trapasso F, Pentimalli F, Barone MV, Chiapetta G, Vento MT, Spiezia S, Fusco A, Viglietto G (1999) Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J Clin Invest 104: 865–874CrossRefGoogle Scholar
  7. 7.
    Bartolone L, Vermiglio F, Finocchiaro MD, Violi MA, French D, Pontecorvi A, Trimarchi F, Benvenga S (1998) Thyroid follicle oncogenesis in iodine deficient and iodine-sufficient areas: search for alterations of the ras, met and BFGF oncogenes and of the Rb anti-oncogene. J Endocrinol Invest 21: 680–687PubMedGoogle Scholar
  8. 8.
    Basolo F, Baloch ZW, Baldanzi A, Miccoli P, LiVolsi VA (1999) Usefulness of Ultrafast Papanicolaou- stained scrape preparations in intraoperative management of thyroid lesions. Mod Pathol 12: 653–657PubMedGoogle Scholar
  9. 9.
    Beimfohr C, Klugbauer S, Demidchik EP, Lengfelder E, Rab es HM (1999) NTKRI re-arrangement in papillary thyroid carcinomas of children alter the Chernobyl reactor accident. Int J Cancer 80: 842–847PubMedCrossRefGoogle Scholar
  10. 10.
    Bellahcene A, Albert V, Pollina L, Basolo F, Fisher LW, Castronovo V (1998) Ectopic expression of bone sialoprotein in human thyroid cancer. Thyroid 8: 637–641PubMedCrossRefGoogle Scholar
  11. 11.
    Berho M, Suster S (1997) The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28: 47–53PubMedCrossRefGoogle Scholar
  12. 12.
    Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B (1997) A comparison of different staging systems predictability of patient’s outcome. Thyroid carcinoma as an example. Cancer 79: 2414–2423Google Scholar
  13. 13.
    Brousset P, Chaouche N, Leprat F, Branet-Brousset F, Trouette H, Zenou RC, Merlio JP, Delsol G (1997) Telomerase activity in human thyroid carcinomas originating from the follicular cells. J Endocrinol Metab 82: 4214–4216CrossRefGoogle Scholar
  14. 14.
    Byar DP, Green SB, Dor P, Williams ED, Colo J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M (1979) A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative Group. Eur J Cancer 15: 1033–1041Google Scholar
  15. 15.
    Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947–953PubMedGoogle Scholar
  16. 16.
    Califano JA, Johns MM, Westra WH, Lango MN, Eisele D, Saji M, Zeiger MA, Udelsman R, Koch WM, Sidransky D (1996) An allelotype of papillary thyroid cancer. Int J Cancer 69: 442–444PubMedCrossRefGoogle Scholar
  17. 17.
    Cameselle-Teijeiro J, Chan JK (1999) Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod Pathol 12: 400–411PubMedGoogle Scholar
  18. 18.
    Canzian F, Amati P, Harach W, Kraimps JL, Lesueur F, Barbier J, Levillain P, Remeo G, Bonneau D (1998) A gene predisposing to familiar thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63: 1743–1748PubMedCrossRefGoogle Scholar
  19. 19.
    Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8: 655–668Google Scholar
  20. 20.
    Cetani F, Tonacchera M, Pinchera A, Barsacchi R, Basolo F, Miccoli P, Pacini F (1999) Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas. J Endocrinol Invest 22: 273–278PubMedGoogle Scholar
  21. 21.
    Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85: 286–292PubMedCrossRefGoogle Scholar
  22. 22.
    Chen BK, Ohtsuki Y, Furihata M, Takeuchi T, lwata J, Liang SB Sonobe H (1999) Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage. Int J Oncol 15: 893–898PubMedGoogle Scholar
  23. 23.
    Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, Ringel M, Parkerson S, Allo M, Udelsman R (1998) Hurtle cell neoplasms of the thyroid: Are there factors predictive of malignancy? Ann Surg 227: 542–546PubMedCrossRefGoogle Scholar
  24. 24.
    Cheng AJ, Lin JD, Chang T, Wang TC (1998) Telomerase activity in benign and malignant human thyroid tissues. Br J Cancer 77: 2177–2180PubMedCrossRefGoogle Scholar
  25. 25.
    Chieng DC, Ross JS, McKenna BJ (1997) CD 44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear grooves and inclusions. Cancer 81: 157–162CrossRefGoogle Scholar
  26. 26.
    Cho JY, Sagartz JE, Capen CC, Mazzaferri EL, Jhiang SM (1999) Early cellular abnormalities induced by RET/PTC 1 oncogene in thyroid-targeted transgenic mice. Oncogene 18: 3659–3665PubMedCrossRefGoogle Scholar
  27. 27.
    Deandrea M, Gallone G, Veglio M, Balsamo A, Grassi A, Sapelli S, Rossi C, Nasi PG, Prorcellana V, Varvello G, Capussotti L, Taraglio S, Ravarino N, Torchio B, Fonzo D (1997) Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period. J Endocrinol Invest 20: 52–58PubMedGoogle Scholar
  28. 28.
    DeGroot LJ, Kaplan EL, McCormick M, Straus FH (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71: 414–424PubMedCrossRefGoogle Scholar
  29. 29.
    Deshpande V, Kapila K, Sai KS, Venna K (1997) Follicular neoplasms of the thyroid. Decision tree approach using morphologic and morphometric parameters. Acta Cytol 41: 369–376Google Scholar
  30. 30.
    Dhar DK, Kubota H, Kotoh T, Tabara H, Watanabe R, Tachibana M, Kohno H, Nagasue N (1998) Tumor vascularity precincts recurrence in differentiated thyroid carcinoma. Am J Surg 176: 442–447PubMedCrossRefGoogle Scholar
  31. 31.
    Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP (1998) Pten is essential for embryonic development and tumor suppression. Nat Genet 19: 348–355PubMedCrossRefGoogle Scholar
  32. 32.
    Eng C, Thomas GA, Neuberg DS, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F, Williams ED, Ponder BA (1998) Mutation of the RET proto-oncogene is correlated with immunostaining in subpopulations of cells in sporadic medullary carcinoma. J Clin Endocrinol Metab 83: 4310–4313PubMedCrossRefGoogle Scholar
  33. 33.
    Evans HL (1986) Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 85: 77–80PubMedGoogle Scholar
  34. 34.
    Evans HL (1996) Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. Am J Surg Pathol 20: 1205–1211PubMedCrossRefGoogle Scholar
  35. 35.
    Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL (1996) Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid 6: 409–416PubMedCrossRefGoogle Scholar
  36. 36.
    Fischer AH, Bond JA, Taysavang P, Battles 0E, Wynford-Thomas D (1998) Papillary thyroid carcinoma oncogene ( RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153: 1443–1450Google Scholar
  37. 37.
    Fontanini G, Vignati S, Pacini F, Pollina L, Basolo F (1996) Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma. Mod Pathol 9: 636–641PubMedGoogle Scholar
  38. 38.
    Franc B, Rosenberg-Bourgin M, Caillou B, Dutrieux-Berger N, Floquet J, Houcke-Lecomte M, Justrabo E, Lange F, Labat-Moleur F, Le Bodic MF, Patey M, Beauchet A, Saint-Andre JP, Hejblum G, Viennet G (1998) Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis). Hum Pathol 29: 1078–1084PubMedCrossRefGoogle Scholar
  39. 39.
    Frittitta L, Sciacca L, Catalfamo R, Ippolito R, Gangemi P, Pezzino V, Filetti V, Vigneri R (1999) Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorgenesis? Cancer 85: 492–498PubMedCrossRefGoogle Scholar
  40. 40.
    Fuchshuber PR, Loree TR, Hicks WL, Cheney RT, Shedd DP (1998) Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol 5: 81–86PubMedCrossRefGoogle Scholar
  41. 41.
    Garcia-Rostan G, Tallini G, Herrero A, D’Aquila TG, Carcangiu ML, Rimm DL (1999) Frequent mutation of beta-catenin in anaplastic thyroid carcinoma. Cancer Res 59: 1811–1815PubMedGoogle Scholar
  42. 42.
    Gauger PG, Reeve TS, Delbridge LW (1999) Intraoperative decision making in follicular lesions of the thyroid: is tumor size important? J Am Coll Surg 189: 253–258PubMedCrossRefGoogle Scholar
  43. 43.
    Gilliland FD, Hunt WC, Morris DM, Key CR (1997) Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer 79: 564–573PubMedCrossRefGoogle Scholar
  44. 44.
    Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B (1998) Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid 8:517–5. 23Google Scholar
  45. 45.
    Goldstein NS, Czako P, Neill JS (2000) Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: A study of 34 patients. Mod Pathol 13: 123–130PubMedCrossRefGoogle Scholar
  46. 46.
    Graff M, Greenberg VE, Herman JG, Westra WH, Boghaert ER, Ain KB, Saji M, Zeiger MA, Zimmer SG, Baylin SB (1998) Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle’s cell, and poorly differentiated thyroid carcinoma. Cancer Res 58: 2063–2066Google Scholar
  47. 47.
    Guyetant S, Dupre F, Bigorgne JC, Franc B, Dutrieux-Berger N, Lecomte-Houcke M, Patey M, Caillou B,Viennet G, Guerin O, Saint-Andre JP (1999) Medullary thyroid microcarcinoma: a clinicopathological retrospective study of 38 patients with no prior familial disease. Hum Pathol 30: 957–963Google Scholar
  48. 48.
    Hales M, Rosenau W, Okerlund MD, Galante M (1982) Carcinoma of the thyroid with a mixed medullary and follicular pattern: Morphologic, immunohistochemical, and clinical laboratory studies. Cancer 50: 1352–1359Google Scholar
  49. 49.
    Haugen BR, Nawaz S, Markham N, Hashizumi T, Shroyer AL, Werness B, Shroyer KR (1997) Telomerase activity in benign and malignant thyroid. Thyroid 7: 337–342PubMedCrossRefGoogle Scholar
  50. 50.
    Hawk WA, Hazard JB (1976) The many appearances of papillary carcinoma of the thyroid. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis. Cleve Clin Q 43: 207–215Google Scholar
  51. 51.
    Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Clin North Am 19: 658–718Google Scholar
  52. 52.
    Hay ID, Bergstralh EJ, Goellner M, Ebersold M, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050–1057PubMedGoogle Scholar
  53. 53.
    Hazard JB (1960) Small papillary carcinoma of the thyroid. A study with special reference to so-called nonencapsulated sclerosing tumor. Lab Invest 9: 86–97PubMedGoogle Scholar
  54. 54.
    Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumors, 2nd edn. International histological classification of tumors No. 11. World Health Organization. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  55. 55.
    Hemmer S, Wasenius VM, Knuutila S, Joensuu H, Franssila K (1998) Comparison of benign and malignant follicular thyroid tumors by comparative genomic hybridization. Br J Cancer 78: 1012–1017PubMedCrossRefGoogle Scholar
  56. 56.
    Hinze R, Holzhausen HJ, Gimm, Rath FW (1998) Primary hereditary medullary thyroid carcinoma-C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch 433: 203–208PubMedCrossRefGoogle Scholar
  57. 57.
    Ho YS, Tseng SC, Chin TY, Hsieh LL, Lin JD (1996) p53 gene mutation in thyroid carcinoma. Cancer Lett 103: 57–63Google Scholar
  58. 58.
    Hofstaedter F (1980) Frequency and morphology of malignant tumors of the thyroid before and after the introduction of iodine-prophylaxis. Virchows Arch A 385: 263–270Google Scholar
  59. 59.
    Hofstaedter F (1980) Electron microscopic investigations about the differentiation of thyroid carcinoma. Pathol Res Pract 169: 304–322CrossRefGoogle Scholar
  60. 60.
    Horii A, Yoshida J, Sakai, M Okamoto S, Honjo Y, Mitani K, Hattori K, Kubo T (1999) Ki-67 positive fractions m benign and malignant thyroid tumors: application of flow cytometry. Acta Otolaryngol 119: 617–620Google Scholar
  61. 61.
    Ishiwata T, Iino Y, Takei H, Oyama T, Morishita Y (1998) Tumor angiogenesis as an independent prognostic indicator in human papillary thyroid carcinoma. Oncol Rep 5: 1343–1348PubMedGoogle Scholar
  62. 62.
    Ito T, Seyama T, Mizuno T (1992) Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52: 1369–1371PubMedGoogle Scholar
  63. 63.
    Ito T, Ito M, Naito S, Ohtsuru A, Nagayama Y, Kanematsu T, Yamashita S, Sekine I (1999) Expression of the Axi receptor tyrosine kinase in human thyroid carcinoma. Thyroid 9: 563–567PubMedCrossRefGoogle Scholar
  64. 64.
    Kakudo K, Shan L, Nakamura Y, Inoue D, Koshiyama H, Sato H (1998) Clonal analysis helps to differentiate aberrant thyroid tissue from thyroid carcinoma. Hum Pathol 29: 187–190PubMedCrossRefGoogle Scholar
  65. 65.
    Kargi A, Yorukoglu Aktas S, Cakalagaoglu E (1996) Neuroendocrine differentiation in nonneuroendocrine thyroid carcinoma. Thyroid 6: 207–210PubMedGoogle Scholar
  66. 66.
    Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I (1998) Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8: 197–202PubMedCrossRefGoogle Scholar
  67. 67.
    Kebebew E, Tresler PA, Siperstein AE, Duh QY, Clark OH (1999) Normal thyroid pathology in patients undergoing thyroidectomy for finding a RET gene germline mutation: a report of three cases and review of the literature. Thyroid: 127–131Google Scholar
  68. 68.
    Khafif A, Khafif RA, Attie JN (1999) Hurthle cell carcinoma: A malignancy of low-grade potential. Head Neck 21: 506–511Google Scholar
  69. 69.
    Khan A, Baker SP, Patwardhan NA, Pullman JM (1998) CD 57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma. Virchows Arch 432: 427–432PubMedCrossRefGoogle Scholar
  70. 70.
    Kim H, Piao Z, Park C, Chung MTY, Park CS (1998) Clinical significance of clonality in thyroid nodules. Br J Surg 85: 1125–1128PubMedCrossRefGoogle Scholar
  71. 71.
    Klinck GH, Winship T (1955) Occult sclerosing carcinoma of the thyroid. Cancer 8: 701–706PubMedCrossRefGoogle Scholar
  72. 72.
    Komoike Y, Tamaki Y, Sakita I, Tornita N, Ohoue M, Sekimoto M, Miyazaki M, Kadota M, Ma-suda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horti A, Monden M (1999) Comparative genomic hybridization defines frequent loss on l6p in human anaplastic thyroid carcinoma. Int J Oncol 14: 157–162Google Scholar
  73. 73.
    Kraemer BB (1987) Frozen section diagnosis and the thyroid. Semin Diagn Pathol 4: 169–189PubMedGoogle Scholar
  74. 74.
    Kurozumi K, Nakao K, Nishida T, Nakahara M, Ogino N, Tsujimoto M (1998) Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma. World J Surg 22: 1237–1242PubMedCrossRefGoogle Scholar
  75. 75.
    LaGuette J, Matias-Guiu X, Rosai J (1997) Thyroid paraganglioma: A clinicopathologic and immunhistochemical study of three cases. Am J Surg Pathol 21: 748–753Google Scholar
  76. 76.
    Lang W, Choritz H, Hundeshagen U (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10: 246–255PubMedCrossRefGoogle Scholar
  77. 77.
    Langhans T (1907) Über die epithelialen Formen der malignen Struma. Virchows Arch 189: 69–188CrossRefGoogle Scholar
  78. 78.
    Lazzereschi D, Palmirotta R, Rarnieri A, Ottini L, Veri MC, Cama A, Cetta F, Nardi F, Coletta G, Mariani-Costantini R (1999) Microsatellite instability in thyroid tumors and tumor-like lesions. Br J Cancer 79: 340–345PubMedCrossRefGoogle Scholar
  79. 79.
    Lindsay S (1960) Carcinoma of the thyroid gland. A clinical and pathological study of 293 patients at the university of California hospital. Thomas, Springfield, IllGoogle Scholar
  80. 80.
    Lo CY, Lam KY, Wan KY (1999) Anaplastic carcinoma of the thyroid. Am J Surg 177: 337–339PubMedCrossRefGoogle Scholar
  81. 81.
    Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP (1997) Pathological tumor-node-metastasis (PTNM) staging for papillary and follicular carcinomas: a retrospective analysis of 700 patients. J Clin Endocr Metab 82: 3553–3562PubMedCrossRefGoogle Scholar
  82. 82.
    Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84: 458–463PubMedCrossRefGoogle Scholar
  83. 83.
    Lupoli G, Vitale G, Caraglia M, Fittipaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR (1999) Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353: 637–639PubMedCrossRefGoogle Scholar
  84. 84.
    Manetto V, Lorenzini R, Cordon-Cardo C, Krajewski S, Rosai J, Reed JC, Eusebi V (1997) Bcl2 and Box expression in thyroid tumors. An immunohistochemical and Western blot analysis. Virchows Arch 430: 125–130Google Scholar
  85. 85.
    Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418–428PubMedCrossRefGoogle Scholar
  86. 86.
    McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61: 978–996PubMedCrossRefGoogle Scholar
  87. 87.
    McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120: 1000–1004PubMedCrossRefGoogle Scholar
  88. 88.
    McHenry CR, Raeburn C, Strickland T, Marty JJ (1996) The utility of routine frozen section examination for intraoperative diagnosis of thyroid cancer. Am J Surg 172: 658–661PubMedCrossRefGoogle Scholar
  89. 89.
    Miki H, Kitaichi M, Masuda E, Komaki K, Yamamoto Y, Monden Y (1999) ret/PTC expression may be associated with local invasion of thyroid papillary carcinoma. J Surg Oncol 71: 76–81Google Scholar
  90. 90.
    Mitsiades N, Poulaki V, Mastorakos G, Tseleni-Balafouta ST, Kotoula V, Koutras DA, Tsokos M (1999) Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion. J Clin Endocrinol Metab 84: 2924–2932PubMedCrossRefGoogle Scholar
  91. 91.
    Moers AM, Lansvater RM, Schaap C, Jansen-Schillhorn van Veen JM, de Valk IA, Blijham GH, Hoppener JW, Vroom TM, van Amstel HK, Lips CJ (1996) Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family. Am J Med 101: 635–641Google Scholar
  92. 92.
    Moreira Leite KR, de Araujo VC, Rezende Meirelles MI, Lopes Costa AD, Camara-Lopes LH (1999) No relationship between proliferative activity and the MACIS prognostic scoring system in papillary thyroid carcinoma. Head Neck 21: 602–605PubMedCrossRefGoogle Scholar
  93. 93.
    Muro-Cacho CA, Munoz-Antonia T, Livingston S, Klotch D (1999) Transforming growth factor beta receptors and p27kip in thyroid carcinoma. Arch Otolaryngol Head Neck Surg 125: 76–81PubMedGoogle Scholar
  94. 94.
    Nagashima T, Suzuki M, Oshida M, Hashimoto FL Yagata H, Shishikura T, Koda K, Nakajima N (1998) Morphometry in the cytological evaluation of thyroid follicular lesions. Cancer 84: 115–118PubMedCrossRefGoogle Scholar
  95. 95.
    Nakayama T, Ito M, Ohtsuru A, Naito S, Nakashima M, Sekine I (1999) Expression of the ets1 proto-oncogene in human thyroid tumor. Mod Pathol 12: 61–68PubMedGoogle Scholar
  96. 96.
    Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA (1997) Distinct pattern of rot oneogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57: 1690–1694PubMedGoogle Scholar
  97. 97.
    Nikiforov YE, Koshoffer A, Nikiforova M, Stringer J, Fagin JA (1999) Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELEI and RET genes in radiation-induced thyroid carcinomas. Oncogene 18: 6330–6334PubMedCrossRefGoogle Scholar
  98. 98.
    Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda U (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23: 205–211PubMedCrossRefGoogle Scholar
  99. 99.
    Orlandei F, Saggiorato E, Pivano G, Puligheddu B, Ternine A, Cappia S, De Giuli P, Angeli A (1998) Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58: 3015–3020Google Scholar
  100. 100.
    Ostrowski ML, Merino MJ (1996) Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparisons to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 20: 964–974PubMedCrossRefGoogle Scholar
  101. 101.
    Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y (1996) Papillary carcinoma of the thyroid. Tall cell variant with extensive lymphocytic infiltration. Am J Surg Pathol 20: 695–698Google Scholar
  102. 102.
    Papotti M, Torchio B, Grassi, L, Favero A, Bussolati G (1996) Poorly differentiated oxyphilic ( Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol 20: 686–694Google Scholar
  103. 103.
    Papahavasit A, Thompson GB, Hay ID, Grant CS, van Heerden JA, Ilstrup DM, Schleck C, Goellner JR (1997) Follicular and Hurthle cell neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 132: 674–678CrossRefGoogle Scholar
  104. 104.
    Passler C, Scheuba, C, Prager G, Kaserer K, Flores JA, Vierhappen H, Niederle B (1999) Anaplastic (undifferentiated) thyroid carcinoma (ATC): a retrospective analysis. Langen-becks Arch Surg 384: 284–293CrossRefGoogle Scholar
  105. 105.
    Perrier ND, van Heerden JA, Goellner JR, Williams ED, Gharib H, Marchesa P, Church JM, Fazio VW, Larson DR (1998) Thyroid cancer in patients with familiar adenomatous polyposis. World J Surg 22: 738–742PubMedCrossRefGoogle Scholar
  106. 106.
    Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, Vigneri P, Cipriani S, Falcetta F, Miceli R, Pierotti MA, Rilke F (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21: 1466–1473PubMedCrossRefGoogle Scholar
  107. 107.
    Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J (1998) The ret/PTC 1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 8: 133–139PubMedCrossRefGoogle Scholar
  108. 108.
    Prasser C, Scheuba C, Prager G, Kaserer K, Flores JA, Vierhapper H, Niederle B (1999) Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langen-becks Arch Surg 384: 284–293Google Scholar
  109. 109.
    Rath-Wolfson L, Koren R,Yaniv E, Sadov R, Gal R (1999) A new rapid technique for the fixation of thyroid gland surgical specimens. Pathol Oncol Res 5: 70–72Google Scholar
  110. 110.
    Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O (1998) Immunhistochemical analysis of p27/kip 1 expression in thyroid carcinoma. Mod Pathol 11: 735–739PubMedGoogle Scholar
  111. 111.
    Roque L, Serpa A, Clode A, Castedo S, Soares J (1999) Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study. Lab Invest 79: 369–378PubMedGoogle Scholar
  112. 112.
    Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. Atlas of Tumor Pathology, third series, vol 5. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  113. 113.
    Rosen Y, Rosenblatt P, Saltzman E (1990) Intraoperative pathologic diagnosis of thyroid neoplasms. Report on experience with 504 specimens. Cancer 66: 2001–2006PubMedCrossRefGoogle Scholar
  114. 114.
    Ruco LP, Ranalli T, Marzullo A, Bianco P, Prat M, Comoglio PM, Baroni CD (1996) Expression of Met protein in thyroid tumors. J Pathol 180: 266–270PubMedCrossRefGoogle Scholar
  115. 115.
    Rüschoff J, Prasser C, Cortez T, Höhne HM, Hohenberger W, Hofstaedter F (1993) Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nuclear features. Am J Surg Pathol 17: 1281–1288PubMedCrossRefGoogle Scholar
  116. 116.
    Ruschenburg I, Kubitz A, Schlott T, Korabiowska M, Droese M (1999) MAGE-1, GAGF,-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goitre. Int J Mol Med 4: 445–448PubMedGoogle Scholar
  117. 117.
    Ruter A, Dreifus J, Jones M, Nishiyama R, Lennquist S (1996) Overexpression of p53 in tall cell variants of papillary thyroid carcinoma. Surgery 120: 1046–1050PubMedCrossRefGoogle Scholar
  118. 118.
    Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathological entity for a high-risk group of papillary and follicular carcinomas. Cancer 52: 1849–1855Google Scholar
  119. 119.
    Sasaki A, Daa T, Kashima K, Yokoyama S, Nakayma I, Noguchi S (1996) Insular component as a risk factor of thyroid carcinoma. Pathol Int 46: 939–946PubMedCrossRefGoogle Scholar
  120. 120.
    Scarpino S, Stoppacciaro A, Colarossi C, Cancellario F, Marzullo A, Marchesi M, Biffoni M, Comoglio PM, Prat M, Ruco LP (1999) Hepatocyte growth factor ( HGF) stimulates tumor invasiveness in papillary carcinoma of the thyroid. J Pathol 189: 570–575Google Scholar
  121. 121.
    Schaffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstaedter F, Schölmerich J, Rüschoff J (1998) Coexisting thyroiditis is associated with lower tumor stage in thyroid carcinoma. Eur J Clin Invest 28: 838–844PubMedCrossRefGoogle Scholar
  122. 122.
    Schmid KW, Tötsch M, Öfner D, Bäcker W, Ladurner D (1997) Minimally invasive follicular thyroid carcinoma: a clinicopathological study. Curr Top Pathol 91: 37–43PubMedCrossRefGoogle Scholar
  123. 123.
    Schröder S, Bäcker W (1986) Clear-cell carcinomas of the thyroid gland. A clinico-pathological study of 13 cases. Histopathology 10: 75–89PubMedCrossRefGoogle Scholar
  124. 124.
    Scopsi L, Sampitro G, Boracchi P, Del Bo R, Gullo M, Placucci M, Pilotti S (1996) Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive cases. Cancer 78: 2173–2183PubMedCrossRefGoogle Scholar
  125. 125.
    Shimizu M, Hirokawa M, Manabe T (1999) Tall cell variant of papillary thyroid carcinoma with foci of columnar cell component. Virchows Arch 434: 173–175PubMedCrossRefGoogle Scholar
  126. 126.
    Shuja S, Cai J, lacobuzio-Donahue C, Zacks J, Beazley RM, Kasznica JM, O’Hara CJ, Hein-mann R, Murnane MJ (1999) Cathepsin B activity and protein levels in thyroid carcinoma, Graves disease, and multinodular goiters. Thyroid 9: 569–577Google Scholar
  127. 127.
    Smit JW, van der Pluijm G, Vloedgraven HJ, Lowik CW, Goslings BM (1998) Role of integrins in the attachment of metastatic follicular thyroid carcinoma cell lines to bone. Thyroid 8: 29–36PubMedCrossRefGoogle Scholar
  128. 128.
    Soares P, Fonseca E, Wynford-Thomas D, Sobrinho-Simoes M (1998) Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive, thyroid neoplasms. J Patrol 185: 71–78Google Scholar
  129. 129.
    Sobin LH, Wittekind Ch (1997) TNM. Classification malignant tumors, 5th edn. Wiley-Liss, New YorkGoogle Scholar
  130. 130.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M (1999) Expression of bd-2, c-erbB-2, p53, and p21 (wafl-cipl) protein in thyroid carcinomas. J Exp Clin Cancer Res 18: 363–367PubMedGoogle Scholar
  131. 131.
    Sturgis CD, Caraway NP, Johnston DA, Sherman SI, Kidd L, Katz RL (1999) Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease. Cancer 87: 155–160PubMedCrossRefGoogle Scholar
  132. 132.
    Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL (1999) Oncogene profile of papillary thyroid carcinoma. Surgery 1251: 46–52CrossRefGoogle Scholar
  133. 133.
    Sugino K, Ito K Jr, Ozaki O, Mirnura T, Iwasaki H, Ito K (1998) Papillary microcarcinoma of the thyroid. J Endocrinol Invest 21: 445–448PubMedGoogle Scholar
  134. 134.
    Sugitani I, Yanagisawa A, Shimizu A, Kato M, Fujimoto Y (1998) Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg 22: 731–737PubMedCrossRefGoogle Scholar
  135. 135.
    Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K, Amino N (1999) Preoperative diagnosis of thyroid papillary and anaplastic carcinoma by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59: 4542–4545PubMedGoogle Scholar
  136. 136.
    Tallini G, Santoro M, Helie M, Carlomagno F, Salvatore G, Chiapetta G, Carcangiu ML, Fusco A (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin Cancer Res 4: 287–294PubMedGoogle Scholar
  137. 137.
    Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML (1999) Downregulation of p27K1P1 and Ki67/Mibl labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23: 678–685PubMedCrossRefGoogle Scholar
  138. 138.
    Tallini G, Hsueh A, Liu S, Garcia-Rostan G, Speicher MR, Ward DC (1999) Frequent chromosomal DNA unbalance in thyroid oncocytic ( Hurtle cell) neoplasms detected by comparative genomic hybridization. Lab Invest 79: 547–555Google Scholar
  139. 139.
    Tonacchera M, Vitti P, Agretti P, Ceccarini G, Perri A, Cavaliere R, Mazzi B, Naccarato AG, Viacava P, Micoli P, Pinchera A, Chiovato L (1999) Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms. J Clin Endocrinol Metab 84: 4155–4158PubMedCrossRefGoogle Scholar
  140. 140.
    Toti P, Tanganelli P, Schurfeld K, Stumpo M, Barbagli L, Vatti R, Luzi P (1999) Scarring in papillary carcinoma of the thyroid: report of two new cases with exuberant nodular fasciitis-He stroma. Histopathology 35: 418–422PubMedCrossRefGoogle Scholar
  141. 141.
    Tronko MD, Bogdanova TI, Komissarenko IV, Epstein OV, Oliynyk V, Kovalenko A, Likhtarev IA, Kairo I, Peters SB, LiVolsi VA (1999) Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics. Cancer 86: 149–156PubMedCrossRefGoogle Scholar
  142. 142.
    Tscholl-Ducommun J, Hedinger CE (1982) Papillary thyroid carcinomas. Morphology and prognosis. Virchows Arch 396: 19–39Google Scholar
  143. 143.
    Tseleni S, Kavantzas N, Yova D, Alexandratu E, Karydakis V, Gogas J, Davaris P (1997) Findings of computerized nuclear morphometry of papillary thyroid carcinoma in correlation with known prognostic factors. J Exp Clin Cancer Res 16: 401–406PubMedGoogle Scholar
  144. 144.
    Tseleni-Balafouta S, Kavantzas N, Alevizaki M, Paraskevakou H, Davaris P (1998) Neuroendocrine differentiation in follicle-cell thyroid carcinoma: correlation to prognostic factors in papillary carcinoma. J Exp Clin Cancer Res 17: 533–537PubMedGoogle Scholar
  145. 145.
    Tworek JA, Giordano TJ, Michael CW (1998) Comparison of intraoperative cytology with frozen sections in the diagnosis of thyroid lesions. Am J Cancer Pathol 110: 456–461Google Scholar
  146. 146.
    Vickery AL, Carcangiu ML, Johannessen W, Sobrinho-Simoes M (1985) Papillary carcinoma. Semin Diagn Pathol 2: 90–100PubMedGoogle Scholar
  147. 147.
    Voutilainen PE, Multanen M, Haapiainen RK, Leppanierni AK, Sivula AH (1999) Anaplastic thyroid carcinoma survival. World J Surg 23: 975–978PubMedCrossRefGoogle Scholar
  148. 148.
    Waldmann V, Rabes HM (1997) Absence of G(s)alpha gene mutations in childhood thyroid tumors alter Chernobyl in contrast to sporadic adult thyroid neoplasia. Cancer Res 57: 2358–2361PubMedGoogle Scholar
  149. 149.
    Walgenbach S, Sternheirn E, Bittinger F, Gorges R, Andreas J, Junginger T (1998) Prognostic value of e-cadherin in papillary thyroid carcinoma. Chirurg 69: 186–190PubMedCrossRefGoogle Scholar
  150. 150.
    Wang S, Wuu J, Savas L, Patwardhan N, Khan A (1998) The role of cell cycle regulators proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum Pathol 29: 1304–1309PubMedCrossRefGoogle Scholar
  151. 151.
    Wilkens L, Benten D, Tchinda J, Brabant G, Pötter E, Dralle H, v Wasielewski R (2000) Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridization and comparative genomic hybridization. Virchows Arch 436: 312–318PubMedCrossRefGoogle Scholar
  152. 152.
    Winzer R, Schmutzler C, Jakobs TC, Ebert R, Rendl J, Reiners C, Jakob F, Kohrle J (1998) Reverse transcriptase-polymerase chain reaction analysis of thyrocyte-relevant genes in fine-needle aspiration biopsies of the human thyroid. Thyroid 8: 981–987PubMedCrossRefGoogle Scholar
  153. 153.
    Wong NA, Willott J, Kendall MJ, Sheffield EA (1999) Measurement of vascularity as a diagnostic and prognostic tool for well differentiated thyroid tumors’ comparison of different methods of assessing vascularity. J Clin Pathol 52: 593–597PubMedCrossRefGoogle Scholar
  154. 154.
    Wynford-Thomas D (1994) Growth factors and oncogenes. In: Wheeler MH, Lazarus JH (eds) Diseases of the thyroid. Chapman and Hall, LondonGoogle Scholar
  155. 155.
    Yunta PJ, Ponce JL, Prieto M, Merino F, Sancho-Fornos S (1999) The importance of a tumor capsule in columnar cell thyroid carcinoma: a report of two cases and review of the literature. Thyroid 9: 15–19CrossRefGoogle Scholar
  156. 156.
    Zeiger MA, Smallridge RC, Clark DP, Liang CK, Carty SE, Watson CG, Udelsman R, Saji M (1999) Human telomerase reverse transcriptase ( HTFRT) gene expression in FNA samples from thyroid neoplasms. Surgery 126: 1195–1198Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • F. Hofstädter

There are no affiliations available

Personalised recommendations